| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.005 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |